Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombocytopenia in pregnancy

H H Billett1

  • 1Department of Pathology, Long Island Jewish Medical Center, New Hyde Park, New York 11042.

Journal of the Association for Academic Minority Physicians : the Official Publication of the Association for Academic Minority Physicians
|January 1, 1994
PubMed
Summary

Pregnancy thrombocytopenia has varied causes, from benign incidental cases to serious conditions like HELLP syndrome. Accurate diagnosis is key for appropriate risk assessment and treatment, ensuring maternal and neonatal well-being.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).

Thrombosis research·2021
Same author

A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience.

Journal of thrombosis and thrombolysis·2008
Same author

Efficacy of inferior vena cava filters in anticoagulated patients.

Journal of thrombosis and haemostasis : JTH·2007
Same author

Liver function tests in sickle cell disease.

Clinical and laboratory haematology·2002
Same author

Racial variation in fasting and random homocysteine levels.

American journal of hematology·2001
Same author

Direct and indirect antithrombins. Heparins, low molecular weight heparins, heparinoids, and hirudin.

Clinics in geriatric medicine·2001

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Maternal-Fetal Medicine

Background:

  • Thrombocytopenia in pregnancy presents diverse clinical implications based on its underlying cause.
  • Distinguishing benign causes from severe conditions is crucial for patient management.

Purpose of the Study:

  • To define the etiologies of thrombocytopenia during pregnancy.
  • To assess the risks and therapeutic strategies for each identified cause.
  • To emphasize the importance of diagnosing incidental thrombocytopenia.

Main Methods:

  • Review of literature on pregnancy-related thrombocytopenia.
  • Analysis of diagnostic criteria for various etiologies.
  • Evaluation of current therapeutic approaches and risk stratification.

Main Results:

  • Incidental thrombocytopenia is the most common and benign entity, requiring reassurance.
  • Severe thrombocytopenia can result from angiopathic conditions including preeclampsia, HELLP syndrome, DIC, TTP, and HUS.
  • Immune thrombocytopenic purpura presents therapeutic controversies regarding maternal risk, delivery, and neonatal treatment.
  • Alloimmune thrombocytopenia necessitates careful risk assessment and specific therapeutic interventions.

Conclusions:

  • Accurate etiological diagnosis of thrombocytopenia in pregnancy is paramount for appropriate management.
  • Timely identification of benign thrombocytopenia prevents unnecessary interventions.
  • Management strategies must be tailored to the specific cause, considering maternal and fetal outcomes.

Related Experiment Videos